Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis.

Authors

Kevin Messacar
Stefan Sillau
Sarah E. Hopkins
Catherine Otten
Molly Wilson-Murphy
Brian Wong
Jonathan D. Santoro
Andrew Treister
Harlori K. Bains
Alcy Torres
Luke Zabrocki
Julia R. Glanternik
Amanda L. Hurst
Jan A. Martin
Teri Schreiner
Naila Makhani
Roberta L. DeBiasi, George Washington University
Michael C. Kruer
Adriana H. Tremoulet
Keith Van Haren
Jay Desai
Leslie A. Benson
Mark P. Gorman
Mark J. Abzug
Kenneth L. Tyler
Samuel R. Dominguez

Document Type

Journal Article

Publication Date

4-30-2019

Journal

Neurology

Volume

92

Issue

18

Inclusive Pages

e2118-e2126

DOI

10.1212/WNL.0000000000006670

Keywords

Antiviral Agents; Central Nervous System Viral Diseases; Child; Child, Preschool; Female; Fluoxetine; Humans; Male; Myelitis; Neuromuscular Diseases; Retrospective Studies; Treatment Outcome

Comments

Epub 2018 Nov 9

APA Citation

Messacar, K., Sillau, S., Hopkins, S. E., Otten, C., Wilson-Murphy, M., Wong, B., Santoro, J. D., Treister, A., Bains, H. K., Torres, A., Zabrocki, L., Glanternik, J. R., Hurst, A. L., Martin, J. A., Schreiner, T., Makhani, N., DeBiasi, R. L., Kruer, M. C., Tremoulet, A. H., Van Haren, K., Desai, J., Benson, L. A., Gorman, M. P., Abzug, M. J., Tyler, K. L., & Dominguez, S. R. (2019). Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis.. Neurology, 92 (18). http://dx.doi.org/10.1212/WNL.0000000000006670

Peer Reviewed

1